MENU
ENLV
AS OF
Feb 4, 04:59 PM (EDT)
Price
$1.09
Change
+$0.01 (+0.92%)
Capitalization
255.19M
21 days until earnings call
Intraday BUY SELL Signals
+Compare
ENLV
Stock ticker: NASDAQ
AS OF
Feb 4, 04:59 PM (EDT)
Price
$1.09
Change
+$0.01 (+0.92%)
Capitalization
255.19M

ENLV Enlivex Therapeutics Ltd Forecast, Technical & Fundamental Analysis

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company... Show more

ENLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ENLV with price predictions
Feb 03, 2026

ENLV in +7.92% Uptrend, rising for three consecutive days on February 03, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ENLV advanced for three days, in of 198 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 08, 2026. You may want to consider a long position or call options on ENLV as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ENLV just turned positive on January 06, 2026. Looking at past instances where ENLV's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

ENLV moved above its 50-day moving average on January 14, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ENLV crossed bullishly above the 50-day moving average on January 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 94 cases where ENLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ENLV moved out of overbought territory on January 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where ENLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ENLV broke above its upper Bollinger Band on January 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.599) is normal, around the industry mean (27.519). P/E Ratio (0.000) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ENLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ENLV is expected to report earnings to rise 21.88% to -14 cents per share on February 25

Enlivex Therapeutics Ltd ENLV Stock Earnings Reports
Q4'25
Est.
$-0.14
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.07
The last earnings report on December 01 showed earnings per share of -11 cents, beating the estimate of -14 cents. With 141.95K shares outstanding, the current market capitalization sits at 255.19M.
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WMMVY32.440.08
+0.25%
Wal-Mart De Mexico S.A.B. de C.V.
DPZUF14.30N/A
N/A
Domino's Pizza Australia New Zealand
SKSUY89.54N/A
N/A
Sekisui Chemical Co.
FPRGF0.37N/A
-1.08%
Falco Resources Ltd.
MGPHF0.07N/A
-3.69%
Mason Resources Inc.

ENLV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
+4.81%
APVO - ENLV
39%
Loosely correlated
-10.34%
FATE - ENLV
32%
Poorly correlated
-5.69%
SLNO - ENLV
29%
Poorly correlated
+3.92%
AXON - ENLV
29%
Poorly correlated
-1.89%
AMRN - ENLV
29%
Poorly correlated
+0.37%
More